Pan Cancer Insights into BAZ1B as a Prognostic and Immunological Marker

Xiaorong Zhao; Yuhu Niu; Qingjuan Li; Yuxuan Zhang; Bo Niu*

Xiaorong Zhao, Yuhu Niu, Qingjuan Li, Yuxuan Zhang and Bo Niu*

Volume3-Issue5
Dates: Received: 2022-05-16 | Accepted: 2022-05-20 | Published: 2022-05-25
Pages: 607-620

Abstract

Background: The Bromodomain Adjacent to the Zinc Finger Domain 1B (BAZ1B) is a versatile nuclear protein. BAZ1B acts on chromatin remodeling, participates in DNA replication and damage repair, and is involved in RNA transcription based on its kinase activity. Although many experimental data support a close relationship between BAZ1B and cancer, its role in pan-cancer remains unclear. Our study aimed to analyze the prognostic and immune functions of BAZ1B expression in different cancers.

Methods: Based on different databases, we investigated the potential carcinogenicity of BAZ1B, including the expression of all TCGA tumors, correlation with prognosis, Tumor Microenvironment (TME), protein phosphorylation, and functional enrichment.

Results: The results showed that BAZ1B was overexpressed in a variety of cancers, and there was a significant correlation between gene mutations and poor prognosis associated with high expression in most cancer patients. We observed elevated phosphorylation levels in breast cancer and lung adenocarcinoma. A significant relationship was also found between BAZ1B expression and TME, including tumor-associated fibroblast infiltration. We also observed that the cellular function of DNA and hepatocellular carcinoma may be related to the molecular mechanism of BAZ1B.

Conclusion: The prognostic and immunological markers of BAZ1B provides a new understanding for future studies in our first pan-cancer analysis.

FullText HTML FullText PDF DOI: 10.37871/jbres1487

Certificate of Publication

Copyright

How to cite this article

Zhao X, Niu Y, Li Q, Zhang Y, Niu B. Pan Cancer Insights into BAZ1B as a Prognostic and Immunological Marker. J Biomed Res Environ Sci. 2022 May 25; 3(5): 607-620. doi: 10.37871/jbres1487, Article ID: JBRES1487, Available at: https://www.jelsciences.com/articles/jbres1487.pdf

Subject area(s)

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018 Mar 23;359(6382):1350-1355. doi: 10.1126/science.aar4060. Epub 2018 Mar 22. PMID: 29567705; PMCID: PMC7391259.
Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-Analyzed Tumors. Cell. 2018 Apr 5;173(2):530. doi: 10.1016/j.cell.2018.03.059. PMID: 29625059.
Clough E, Barrett T. The Gene Expression Omnibus Database. Methods Mol Biol. 2016;1418:93-110. doi: 10.1007/978-1-4939-3578-9_5. PMID: 27008011; PMCID: PMC4944384.
Peoples RJ, Cisco MJ, Kaplan P, Francke U. Identification of the WBSCR9 gene, encoding a novel transcriptional regulator, in the Williams-Beuren syndrome deletion at 7q11.23. Cytogenet Cell Genet. 1998;82(3-4):238-46. doi: 10.1159/000015110. PMID: 9858827.
Sharif SB, Zamani N, Chadwick BP. BAZ1B the Protean Protein. Genes (Basel). 2021 Sep 28;12(10):1541. doi: 10.3390/genes12101541. PMID: 34680936; PMCID: PMC8536118.
Lundqvist J, Kirkegaard T, Laenkholm AV, Duun-Henriksen AK, Bak M, Feldman D, Lykkesfeldt AE. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 2018 Mar;177:171-178. doi: 10.1016/j.jsbmb.2017.06.003. Epub 2017 Jun 10. PMID: 28610873.
Liu Y, Wang SQ, Long YH, Chen S, Li YF, Zhang JH. KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway. Oncotarget. 2016 Aug 16;7(33):53153-53164. doi: 10.18632/oncotarget.10625. PMID: 27449290; PMCID: PMC5288175.
Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun Y, Liang XH, Wang JB, Mei QB, Zhang F, Zhang T. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Cell Signal. 2016 Nov;28(11):1673-82. doi: 10.1016/j.cellsig.2016.07.008. Epub 2016 Jul 21. PMID: 27449264.
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407. PMID: 32442275; PMCID: PMC7319575.
Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560. doi: 10.1093/nar/gkz430. PMID: 31114875; PMCID: PMC6602440.
Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, Varambally S. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017 Aug;19(8):649-658. doi: 10.1016/j.neo.2017.05.002. Epub 2017 Jul 18. PMID: 28732212; PMCID: PMC5516091.
Thul PJ, Lindskog C. The human protein atlas: A spatial map of the human proteome. Protein Sci. 2018 Jan;27(1):233-244. doi: 10.1002/pro.3307. Epub 2017 Oct 10. PMID: 28940711; PMCID: PMC5734309.
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4. doi: 10.1158/2159-8290.CD-12-0095. Erratum in: Cancer Discov. 2012 Oct;2(10):960. PMID: 22588877; PMCID: PMC3956037.
Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, Chan NW, Zhang J. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019 Oct 15;35(20):4200-4202. doi: 10.1093/bioinformatics/btz210. PMID: 30903160.
Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, von Mering C. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612. doi: 10.1093/nar/gkaa1074. Erratum in: Nucleic Acids Res. 2021 Oct 11;49(18):10800. PMID: 33237311; PMCID: PMC7779004.
Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014 Aug 29;15(1):293. doi: 10.1186/1471-2105-15-293. PMID: 25176396; PMCID: PMC4261873.
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4(5):P3. Epub 2003 Apr 3. PMID: 12734009.
Kumar A, Watkins R, Vilgelm AE. Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer. Front Immunol. 2021 Jun 1;12:690499. doi: 10.3389/fimmu.2021.690499. PMID: 34140957; PMCID: PMC8204054.
Stevanović S, Draper LM, Langhan MM, Campbell TE, Kwong ML, Wunderlich JR, Dudley ME, Yang JC, Sherry RM, Kammula US, Restifo NP, Rosenberg SA, Hinrichs CS. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. J Clin Oncol. 2015 May 10;33(14):1543-50. doi: 10.1200/JCO.2014.58.9093. Epub 2015 Mar 30. PMID: 25823737; PMCID: PMC4417725.
Li J, Chen QY, He J, Li ZL, Tang XF, Chen SP, Xie CM, Li YQ, Huang LX, Ye SB, Ke M, Tang LQ, Liu H, Zhang L, Guo SS, Xia JC, Zhang XS, Zheng LM, Guo X, Qian CN, Mai HQ, Zeng YX. Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Oncoimmunology. 2015 Mar 6;4(2):e976507. doi: 10.4161/23723556.2014.976507. PMID: 25949875; PMCID: PMC4404907.
Pedersen M, Westergaard MCW, Milne K, Nielsen M, Borch TH, Poulsen LG, Hendel HW, Kennedy M, Briggs G, Ledoux S, Nøttrup TJ, Andersen P, Hasselager T, Met Ö, Nelson BH, Donia M, Svane IM. Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study. Oncoimmunology. 2018 Sep 26;7(12):e1502905. doi: 10.1080/2162402X.2018.1502905. PMID: 30524900; PMCID: PMC6279323.
Besser MJ, Shapira-Frommer R, Schachter J. Tumor-Infiltrating Lymphocytes: Clinical Experience. Cancer J. 2015 Nov-Dec;21(6):465-9. doi: 10.1097/PPO.0000000000000154. PMID: 26588677.
Jiang X, Xu J, Liu M, Xing H, Wang Z, Huang L, Mellor AL, Wang W, Wu S. Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities. Cancer Lett. 2019 Oct 10;462:23-32. doi: 10.1016/j.canlet.2019.07.017. Epub 2019 Jul 26. PMID: 31356845.
Mittal D, Lepletier A, Madore J, Aguilera AR, Stannard K, Blake SJ, Whitehall VLJ, Liu C, Bettington ML, Takeda K, Long GV, Scolyer RA, Lan R, Siemers N, Korman A, Teng MWL, Johnston RJ, Dougall WC, Smyth MJ. CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function. Cancer Immunol Res. 2019 Apr;7(4):559-571. doi: 10.1158/2326-6066.CIR-18-0637. Epub 2019 Mar 20. PMID: 30894377; PMCID: PMC6445751.
Kampan NC, Xiang SD, McNally OM, Stephens AN, Quinn MA, Plebanski M. Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities. Curr Med Chem. 2018;25(36):4785-4806. doi: 10.2174/0929867324666170712160621. PMID: 28707587.
Taher MY, Davies DM, Maher J. The role of the interleukin (IL)-6/IL-6 receptor axis in cancer. Biochem Soc Trans. 2018 Dec 17;46(6):1449-1462. doi: 10.1042/BST20180136. Epub 2018 Nov 22. PMID: 30467123.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5. PMID: 32025007; PMCID: PMC7025898.
Huntsman DG, Ladanyi M. The molecular pathology of cancer: from pan-genomics to post-genomics. J Pathol. 2018 Apr;244(5):509-511. doi: 10.1002/path.5057. PMID: 29436707.
Srivastava S, Hanash S. Pan-Cancer Early Detection: Hype or Hope? Cancer Cell. 2020 Jul 13;38(1):23-24. doi: 10.1016/j.ccell.2020.05.021. Epub 2020 Jun 11. PMID: 32531269.
Xiao A, Li H, Shechter D, Ahn S, Fabrizio L, Erdjument-Bromage H, et al. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature. 2009;457(7225):57-62. doi: 10.1038/nature07668. PubMed PMID: 19092802.
Zhou J, Zheng Y, Liang G, Xu X, Liu J, Chen S, Ge T, Wen P, Zhang Y, Liu X, Zhuang J, Wu Y, Chen J. Atypical deletion of Williams-Beuren syndrome reveals the mechanism of neurodevelopmental disorders. BMC Med Genomics. 2022 Apr 4;15(1):79. doi: 10.1186/s12920-022-01227-7. PMID: 35379245; PMCID: PMC8981662.
Sun H, Martin JA, Werner CT, Wang ZJ, Damez-Werno DM, Scobie KN, Shao NY, Dias C, Rabkin J, Koo JW, Gancarz AM, Mouzon EA, Neve RL, Shen L, Dietz DM, Nestler EJ. BAZ1B in Nucleus Accumbens Regulates Reward-Related Behaviors in Response to Distinct Emotional Stimuli. J Neurosci. 2016 Apr 6;36(14):3954-61. doi: 10.1523/JNEUROSCI.3254-15.2016. PMID: 27053203; PMCID: PMC4821908.
Barnett C, Krebs JE. WSTF does it all: a multifunctional protein in transcription, repair, and replication. Biochem Cell Biol. 2011 Feb;89(1):12-23. doi: 10.1139/O10-114. Erratum in: Biochem Cell Biol. 2015 Aug;93(4):421. PMID: 21326359; PMCID: PMC3251257.
Oppikofer M, Sagolla M, Haley B, Zhang HM, Kummerfeld SK, Sudhamsu J, Flynn EM, Bai T, Zhang J, Ciferri C, Cochran AG. Non-canonical reader modules of BAZ1A promote recovery from DNA damage. Nat Commun. 2017 Oct 11;8(1):862. doi: 10.1038/s41467-017-00866-0. PMID: 29021563; PMCID: PMC5636791.
Karamitopoulou E, Andreou A, Wenning AS, Gloor B, Perren A. High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity. Eur J Cancer. 2022 May 2;169:64-73. doi: 10.1016/j.ejca.2022.03.033. Epub ahead of print. PMID: 35512587.
Kozel BA, Barak B, Kim CA, Mervis CB, Osborne LR, Porter M, Pober BR. Williams syndrome. Nat Rev Dis Primers. 2021 Jun 17;7(1):42. doi: 10.1038/s41572-021-00276-z. PMID: 34140529.
Yang L, Du C, Chen H, Diao Z. Downregulation of Williams syndrome transcription factor (WSTF) suppresses glioblastoma cell growth and invasion by inhibiting PI3K/AKT signal pathway. Eur J Histochem. 2021 Nov 17;65(4):3255. doi: 10.4081/ejh.2021.3255. PMID: 34784707; PMCID: PMC8611414.
Jiang D, Ren C, Yang L, Li F, Yang X, Zheng Y, Ji X, Tian Y. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway. J Obstet Gynaecol Res. 2021 Jul;47(7):2433-2441. doi: 10.1111/jog.14813. Epub 2021 May 24. PMID: 34028125.
Lundqvist J, Hansen SK, Lykkesfeldt AE. Vitamin D analog EB1089 inhibits aromatase expression by dissociation of comodulator WSTF from the CYP19A1 promoter-a new regulatory pathway for aromatase. Biochim Biophys Acta. 2013 Jan;1833(1):40-7. doi: 10.1016/j.bbamcr.2012.10.012. Epub 2012 Oct 18. PMID: 23085504.